About CagriSema CagriSema is being investigated by Novo Nordisk as a once-weekly subcutaneous injectable treatment for adults with overweight or obesity (REDEFINE program) and as a treatment for adults with type 2 diabetes (REIMAGINE program)
Weeks 12 through 24 allow for progressive loading: increasing resistance in strength training, adding moderate-intensity cardio, and returning to pre-pregnancy activities as tolerated
Genetics and family history can play a significant role, making certain individuals more predisposed to developing this condition
Introduction Feeling nervous before an injection does not mean you are doing anything wrong
Follow a vitamin-rich diet, focusing on foods rich in vitamins C and E, to support the continued effects of glutathione
#WorkingMom @joinmochisocials @drmyramochi @myrajoinmochi #j #joi @joinmochisocials @drmyramochi @myrajoinmochi #joinmochi #mochihealth #mochipartner @joinmochisocials @drmyramochi @myrajoinmochi #joinmochi #mochihealth #mochipartner @joinmochisocials @drmyramochi @myrajoinmochi #joinmochi #mochihealth #mochipartner Shouldnt we just celebrate all weight loss